Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno- globulin E

By Quist Sven R.   Ambach Andreas   Göppner Daniela   Quist Jennifer   Franke Ingolf   Bonnekoh Bernd   Gollnick Harald P.M.  

Acta Dermato-Venereologica, Vol. 93, Iss. 2, 2013-03 ,pp. : 206-208

Medical Journals Limited

Access to resources Recommend Favorite

Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis

By Luger TA   Lahfa M   Fölster-Holst R   Gulliver WP   Allen R   Molloy S   Barbier N   Paul C   Bos JD  

Journal of Dermatological Treatment, Vol. 15, Iss. 3, 2004-06 ,pp. : 169-178

Informa Healthcare

Access to resources Recommend Favorite

Serum Creatinine Levels During and After Long-term Treatment with Cyclosporine A in Patients with Severe Atopic Dermatitis

By  

Acta Dermato-Venereologica, Vol. 95, Iss. 8, 2015-11 ,pp. : 963-967

Medical Journals Limited

Access to resources Recommend Favorite

Activation Markers in Severe Atopic Dermatitis Following Extracorporeal Photochemotherapy

By Radenhausen Michael   Radenhausen Michael   Radenhausen Michael   Radenhausen Michael   Radenhausen Michael  

Acta Dermato-Venereologica, Vol. 83, Iss. 1, 2003-01 ,pp. : 49-78

Medical Journals Limited

Access to resources Recommend Favorite

Long-term Treatment with 0.1% Tacrolimus Ointment in Adults with Atopic Dermatitis: Results of a Two-year, Multicentre, Non-comparative Study

By Reitamo Sakari   Ortonne Jean-Paul   Sand Carsten   Bos Jan   Cambazard Frédéric   Bieber Thomas   Grønhøj-Larsen Christian   Rustin Malcolm   Fölster-Holst Regina   Schuttelaar Marie  

Acta Dermato-Venereologica, Vol. 87, Iss. 5, 2007-09 ,pp. : 406-412

Medical Journals Limited

Access to resources Recommend Favorite